• MAPK Regulators of ECM Internalisation Drive Cancer Invasion

  2026-07-10

  Martinez et al. (2024) developed a high-content screening assay to uncover novel kinase regulators of extracellular matrix (ECM) internalisation in invasive carcinoma cells. They identified the α2β1 integrin/p38 MAPK axis as a critical driver of ECM endocytosis and cell migration, with implications for understanding and targeting cancer invasiveness.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-09

  This study reveals that high extracellular fluid viscosity in the tumor microenvironment promotes chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through a mechanobiological signaling cascade. The findings highlight mechanical cues as critical regulators of drug resistance and suggest new avenues for overcoming transporter-mediated chemoresistance.

• Difloxacin HCl: Mechanistic Insights for Next-Generation Ant

  2026-07-09

  Explore the scientific foundation and innovative applications of Difloxacin HCl, a quinolone antimicrobial antibiotic, in advanced susceptibility testing and multidrug resistance research. This article uniquely bridges mechanistic understanding with assay optimization for research excellence.

• Docetaxel (SKU A4394): Practical Answers for Reliable Assays

  2026-07-08

  This article delivers scenario-driven, evidence-backed guidance for applying Docetaxel (SKU A4394) in cancer cell viability, proliferation, and cytotoxicity workflows. Drawing on peer-reviewed research and product data, it addresses common laboratory challenges and positions APExBIO's Docetaxel as a robust solution for reproducible oncology assays.

• DiscoveryProbe FDA-approved Drug Library: Evidence, Action,

  2026-07-08

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) is a rigorously curated set of 2,320 clinically approved bioactive compounds. This library accelerates drug repositioning screening and pharmacological target identification by providing pre-dissolved, mechanism-diverse molecules for high-throughput and high-content assays.

• Tiamulin (Thiamutilin): Bridging Antibacterial and Anti-Infl

  2026-07-07

  This thought-leadership article delivers an advanced, evidence-driven exploration of Tiamulin (Thiamutilin) as both a veterinary antibiotic and a dual-action research tool for translational applications. We integrate mechanistic, pharmacokinetic, and workflow insights—anchored by recent metabolomics and signaling studies—to guide translational researchers seeking to leverage its unique antibacterial and anti-inflammatory properties. This piece moves beyond standard product descriptions, offering a strategic roadmap for experimental optimization and domain-bridging innovation.

• DiscoveryProbe Bioactive Compound Library Plus: Mechanisms a

  2026-07-07

  The DiscoveryProbe Bioactive Compound Library Plus offers 5,072 cell-permeable bioactive compounds for pathway analysis and high-throughput screening. Its rigorous quality control and coverage of diverse targets support advanced cancer and immunology research. Evidence-backed protocols and clear boundaries distinguish its optimal use.

• Linoleic Acid (C18:2(9Z,12Z)): Technical Use and Workflow Gu

  2026-07-06

  Linoleic Acid (C18:2(9Z,12Z)) is essential for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in cell-based and animal protocols where aqueous solubility is not required. It should not be used in workflows needing stable, long-term stock solutions or direct water solubilization. This guide details actionable parameters, workflow design, and troubleshooting for research applications.

• Applied Workflows with Doxorubicin Hydrochloride in Cancer R

  2026-07-06

  Doxorubicin hydrochloride (Adriamycin HCl) empowers cutting-edge cancer chemotherapy research by enabling precise DNA damage and cardiotoxicity modeling. This article delivers actionable, evidence-backed workflows and troubleshooting insights, ensuring reproducibility and data integrity across both cellular and in vivo studies.

• NU7441 (KU-57788) in DNA Repair Research: Protocols & Insigh

  2026-07-05

  NU7441 (KU-57788) is redefining DNA repair and oncology research by enabling sensitive, reproducible assays for DNA-PK–driven pathways. This guide distills advanced experimental workflows, troubleshooting strategies, and key translational applications, spotlighting APExBIO's high-purity inhibitor as a benchmark tool for dissecting DNA damage response.

• Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici

  2026-07-04

  The referenced study demonstrates that IEM-1925, a dual AMPA/NMDA receptor antagonist, provides superior antiseizure, neuroprotective, and cognitive-enhancing effects compared to current standards in a rat model of soman-induced status epilepticus. These findings highlight the significance of targeting glutamate receptor-mediated excitotoxicity for neuroprotection in organophosphorus nerve agent exposure.

• Optimizing Immune Assays with Recombinant Human IL-15 (E.col

  2026-07-03

  This article provides a scenario-driven, evidence-based guide for leveraging Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) (SKU P1029) to address common laboratory challenges in cell proliferation, viability, and immune modulation assays. By integrating validated protocols, quantitative performance metrics, and real-world troubleshooting insights, researchers can achieve higher assay reproducibility and interpretability.

• Optimizing Reporter Assays with EZ Cap™ Firefly Luciferase m

  2026-07-03

  This article provides a scenario-driven guide for biomedical researchers and laboratory professionals seeking reliable, quantitative solutions for gene expression and viability assays. Using SKU R1018, EZ Cap™ Firefly Luciferase mRNA, we dissect common lab challenges, offer protocol insights, and reference peer-reviewed data supporting its performance. Emphasis is placed on reproducibility, translation efficiency, and practical workflow enhancements.

• Practical Use of Angiotensin I/II (1-5) in RAS Research

  2026-07-02

  Angiotensin I/II (1-5) provides a standardized Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of blood pressure regulation and aldosterone signaling in cardiovascular and renal research workflows. It is not suitable for unrelated peptide signaling studies or off-target mechanistic exploration due to its defined solubility and narrow application. Use is recommended where controlled, reproducible peptide handling within the renin-angiotensin system (RAS) is essential.

• Linoleic Acid (C18:2(9Z,12Z)): Technical Use and Protocols

  2026-07-02

  Linoleic Acid (SKU C3108) is a practical tool for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in cell-based and animal workflows. It is not suitable for aqueous protocols or applications requiring long-term stock solution storage. Researchers should use freshly prepared solutions and validated protocols to ensure experimental consistency.

15157 records 1/1011 page Next 12345 下5页 Last page